Exercise,Metabolic Syndrome and Weight Regain (Echocardiography Substudy)

NCT ID: NCT00543985

Last Updated: 2017-03-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We plan to test the hypothesis that patients with metabolic syndrome will have impaired left ventricular diastolic parameters. These parameters will be measured before and after a stress test at the end of a 3 month period of exercise training and a 10% weight loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients must have 2 of the 5 criteria for metabolic syndrome and be able to exercise in a monitored setting for 45 min 5 times a week.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stress Echocardiography

Echocardiography was performed prior to and within 60 seconds of completing the standard Bruce treadmill protocol.

Group Type EXPERIMENTAL

Stress Echocardiography

Intervention Type PROCEDURE

Echocardiography was performs prior to and within 60 seconds of completing the standard Bruce treadmill protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress Echocardiography

Echocardiography was performs prior to and within 60 seconds of completing the standard Bruce treadmill protocol.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 2 of 5 criteria for metabolic syndrome
* Ability to exercise for 45 min 5 days a week

Exclusion Criteria

* No diabetes
* Established coronary disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Missouri-Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tom R Thomas, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Kevin C Dellsperger, MD, PhD

Role: STUDY_DIRECTOR

University of Missouri-Columbia

Anand Chockalingam, MD

Role: STUDY_DIRECTOR

University of Missouri-Columbia

References

Explore related publications, articles, or registry entries linked to this study.

Chockalingam A, Linden MA, Dellsperger KC, Thomas TR. Correlation of Normal Diastolic Cardiac Function With VO in the Metabolic Syndrome. Prev Cardiol. 2009 Summer;12(3):163-8. doi: 10.1111/j.1751-7141.2009.00027.x.

Reference Type RESULT
PMID: 19523060 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DK067036

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01DK067036 (Echo substudy)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.